Theratechnologies Inc.
Theratechnologies Inc., a biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatm… Read more
Market Cap & Net Worth: Theratechnologies Inc. (THTX)
Theratechnologies Inc. (NASDAQ:THTX) has a market capitalization of $155.87 Million ($155.87 Million) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #17132 globally and #6532 in its home market, demonstrating a 2.73% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Theratechnologies Inc.'s stock price $3.39 by its total outstanding shares 45980019 (45.98 Million).
Theratechnologies Inc. Market Cap History: 2015 to 2025
Theratechnologies Inc.'s market capitalization history from 2015 to 2025. Data shows change from $248.29 Million to $155.87 Million (-5.12% CAGR).
Index Memberships
Theratechnologies Inc. is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.01% | #464 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.00% | #1602 of 3165 |
Weight: Theratechnologies Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Theratechnologies Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Theratechnologies Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.97x
Theratechnologies Inc.'s market cap is 0.97 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $248.29 Million | $22.48 Million | $1.17 Million | 11.05x | 211.33x |
| 2016 | $382.55 Million | $27.59 Million | $305.16K | 13.86x | 1253.60x |
| 2017 | $1.05 Billion | $33.31 Million | -$14.34 Million | 31.64x | N/A |
| 2018 | $1.12 Billion | $44.10 Million | -$4.70 Million | 25.44x | N/A |
| 2019 | $606.94 Million | $63.22 Million | -$12.50 Million | 9.60x | N/A |
| 2020 | $459.80 Million | $66.05 Million | -$22.67 Million | 6.96x | N/A |
| 2021 | $557.28 Million | $69.82 Million | -$31.73 Million | 7.98x | N/A |
| 2022 | $161.85 Million | $80.06 Million | -$47.24 Million | 2.02x | N/A |
| 2023 | $74.49 Million | $81.76 Million | -$23.96 Million | 0.91x | N/A |
| 2024 | $83.22 Million | $85.87 Million | -$8.31 Million | 0.97x | N/A |
Competitor Companies of THTX by Market Capitalization
Companies near Theratechnologies Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to Theratechnologies Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Theratechnologies Inc. Historical Marketcap From 2015 to 2025
Between 2015 and today, Theratechnologies Inc.'s market cap moved from $248.29 Million to $ 155.87 Million, with a yearly change of -5.12%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $155.87 Million | +87.29% |
| 2024 | $83.22 Million | +11.73% |
| 2023 | $74.49 Million | -53.98% |
| 2022 | $161.85 Million | -70.96% |
| 2021 | $557.28 Million | +21.20% |
| 2020 | $459.80 Million | -24.24% |
| 2019 | $606.94 Million | -45.90% |
| 2018 | $1.12 Billion | +6.46% |
| 2017 | $1.05 Billion | +175.48% |
| 2016 | $382.55 Million | +54.07% |
| 2015 | $248.29 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Theratechnologies Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $155.87 Million USD |
| MoneyControl | $155.87 Million USD |
| MarketWatch | $155.87 Million USD |
| marketcap.company | $155.87 Million USD |
| Reuters | $155.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.